LAURA COTTER: Open Payments
NPI 1477015378 · ONTARIO, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 11 payments from 7 companies in 2025. Trend: 2023 $170 · 2024 $321 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| Astellas Pharma US Inc | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Abbott Laboratories | 1 | $24 |
| Novo Nordisk Inc | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
Products named: LEQVIO, Veozah, ELIQUIS, PORTICO, Ozempic, XIFAXAN, MOUNJARO.
Industry payments across OR — which companies pay providers there.
